Phthalic Acid

Phthalic Acid

SCHEMBL4095977

CCCCCC(C)C.CCCCCC(C)C.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.66
KDM4E B2RXH2 2/20 0.51
MEN1 O00255 1/20 0.51
RECQL P46063 1/20 0.51
KMT2A Q03164 1/20 0.51
ALOX15 P16050 1/20 0.50
TSHR P16473 4/20 0.49
CA12 O43570 2/20 0.48
CA9 Q16790 2/20 0.48
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
HSD17B10 Q99714 1/20 0.47
CNR2 P34972 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK1 P28482 1/20 0.46
LMNA P02545 1/20 0.45
PTPN11 Q06124 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL81278 0.88 ALDH1A1 (0.68) ALDH1A1KDM4EMEN1RECQLKMT2A
SCHEMBL7859280 0.87 ALDH1A1 (0.71) ALDH1A1KDM4EMEN1RECQLKMT2A
Phthalic Acid SCHEMBL29248354 0.86 ALDH1A1 (0.67) ALDH1A1KDM4EMEN1RECQLKMT2A
Phthalic Acid SCHEMBL28573360 0.86 ALDH1A1 (0.62) ALDH1A1KDM4EMEN1RECQLKMT2A
Phthalic Acid SCHEMBL3775119 0.86 ALDH1A1 (0.67) ALDH1A1KDM4EMEN1RECQLKMT2A
Phthalic Acid SCHEMBL28780791 0.86 ALDH1A1 (0.62) ALDH1A1KDM4EMEN1RECQLKMT2A
Phthalic Acid SCHEMBL30004352 0.86 ALDH1A1 (0.56) ALDH1A1KDM4EMEN1RECQLKMT2A
SCHEMBL7867317 0.86 ALDH1A1 (0.74) ALDH1A1KDM4EMEN1RECQLKMT2A
SCHEMBL11591181 0.86 ALDH1A1 (0.74) ALDH1A1KDM4EMEN1RECQLKMT2A
SCHEMBL234832 0.86 ALDH1A1 (0.74) ALDH1A1KDM4EMEN1RECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993580-A1 COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION Moleac Pte Ltd. (SG) 2008-11-26 EP claimed
WO-2007106049-A1 COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION MOLEAC PTE LTD (SG) 2007-09-20 WO claimed
EP-2508191-A1 Combination therapy for treatment of patients with neurological disorders and cerebral infarction Moleac Pte Ltd. (SG) 2012-10-10 EP disclosed
US-20090162459-A1 Combination Therapy for Treatment of Patients with Neurological Disorders and Cerebral Infarction MOLEAC PTE. LTD (SG) 2009-06-25 US disclosed
EP-1993580-A1 COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION Moleac Pte Ltd. (SG) 2008-11-26 EP disclosed
WO-2007106049-A1 COMBINATION THERAPY FOR TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND CEREBRAL INFARCTION MOLEAC PTE LTD (SG) 2007-09-20 WO disclosed